Pfizer Sues Ranbaxy, Teva Over Accupril Patent

Law360, New York (February 21, 2005, 12:00 AM EST) -- Pfizer Inc. has sued India’s Ranbaxy and Israel’s Teva Pharmaceuticals in New Jersey federal court, alleging that the two companies are infringing a process patent for the hypertension drug Accupril.

The lawsuit, filed in late January in the U.S. District Court for the District of New Jersey, alleges that Ranbaxy infringes a process patent held by Parke-Davis, which was later acquired by Pfizer.

Ranbaxy's generic version reaches the U.S. market under Teva’s label through a supply agreement between the two companies.

Teva was granted six-month marketing...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.